American Rhinologic Society 70th Annual Meeting 2024
Include: 64 videos + 1 pdf, size: 2.49 GB Target Audience: otolaryngologists, rhinologists and sinus surgeons Information: The 70th Annual Meeting of the American Rhinologic Society (ARS) will take place on September 27–28, 2024, at the Fontainebleau Miami Beach in Miami, Florida. Here’s what you can expect:- Scientific Program: Presentations on cutting-edge research, including topics like machine learning in endoscopy and sinonasal pathology
- Networking: A chance to connect with leaders in rhinology and sinus surgery
- Poster Awards: Recognizing outstanding research contributions
- Otolaryngologists (ENT specialists)
- Rhinologists and sinus surgeons
- Physician assistants and advanced practice providers in ENT
- Medical researchers and academics in rhinologic science
- Residents and fellows specializing in otolaryngology
- ARS.70thAnnMtg.PAAG.pdf
- Day 1 General Session 20th Annual David Kennedy Lectureship Drug Development- From Discovery to the Clinic.mp4
- Day 1 General Session AI prediction of IP conversion to SCC using a multi-institutional CT dataset.mp4
- Day 1 General Session Awards Ceremony IFAR Top Reviewers Recognition 1.mp4
- Day 1 General Session Awards Ceremony IFAR Top Reviewers Recognition 2.mp4
- Day 1 General Session Deletion of Nrf2 enhances susceptibility to type 2 inflammation after short term PM2.5 exposure.mp4
- Day 1 General Session Long term outcomes of PRP injections for postviral olfactory loss.mp4
- Day 1 General Session Maurice Cottle – Our Founder Tribute.mp4
- Day 1 General Session Murine model of nose-to-brain delivery of antibodies using minimally invasive nasal depot (MIND).mp4
- Day 1 General Session Panel- CRS- Where are we Headed in Research and Patient Care.mp4
- Day 1 General Session Pathologic dural invasion is associated with regional recurrence in olfactory neuroblastoma.mp4
- Day 1 General Session President’s Address.mp4
- Day 1 General Session Q&A 1.mp4
- Day 1 General Session Q&A 2.mp4
- Day 1 General Session Sinus microbial community changes in chronic rhinosinusitis over one year.mp4
- Day 1 General Session Stem cell therapy to treat Cystic Fibrosis rhinosinusitis.mp4
- Day 1 General Session Steroid-eluting sinus stent versus steroid rinse for maintaining frontal sinus patency.mp4
- Day 1 General Session The effects of allergen immunotherapy (AIT) postsurgery in patients with central compartment atopic disease (CCAD).mp4
- Day 1 General Session Therapeutic efficacy of the Ciprofloxacin Azithromycin sinus stent for p.aeruginosa sinusitis.mp4
- Day 2 General Session 3rd Annual Hwang Family Lectureship.mp4
- Day 2 General Session ARS Business Meeting and Presidential Citations.mp4
- Day 2 General Session Autonomic dysfunction and olfactory loss in long COVID.mp4
- Day 2 General Session Deep learning approach for automated frontal sinus opacification assessment on CT scan.mp4
- Day 2 General Session Immunophenotyping invasive fungal sinusitis survival.mp4
- Day 2 General Session Inflammatory endotypes in CRSwNP- Implications for postop outcomes.mp4
- Day 2 General Session International Panel- “Real World Management of Non-Type 2 CRS Inflammation- A Case-Based Discussion” 1.mp4
- Day 2 General Session International Panel- “Real World Management of Non-Type 2 CRS Inflammation- A Case-Based Discussion” 2.mp4
- Day 2 General Session International Panel- “Real World Management of Non-Type 2 CRS Inflammation- A Case-Based Discussion” 3.mp4
- Day 2 General Session International Panel- “Real World Management of Non-Type 2 CRS Inflammation- A Case-Based Discussion” 4.mp4
- Day 2 General Session International Panel- “Real World Management of Non-Type 2 CRS Inflammation- A Case-Based Discussion” 5.mp4
- Day 2 General Session Intro.mp4
- Day 2 General Session Olfactory cleft opacification and outcomes improve with expanded intranasal steroid treatment.mp4
- Day 2 General Session Olfactory fossa opacification on CT scan is correlated to nasal IL-5 in chronic rhinosinusitis.mp4
- Day 2 General Session Panel- ARS AAOA – Empty Nose Syndrome- Just a Bunch of Hot Air.mp4
- Day 2 General Session PAR2 activated IL13 Ra1 in eCRS.mp4
- Day 2 General Session Prevalence of Cystic Fibrosis carrier status in chronic rhinosinusitis without nasal polyps.mp4
- Day 2 General Session Q&A 1.mp4
- Day 2 General Session Q&A 2.mp4
- Day 2 General Session Token of appreciation.mp4
- Day 2 Skull Base – Breakout 1 Assessing complications of functional endoscopic sinus surgery in a large national database.mp4
- Day 2 Skull Base – Breakout 1 Assessing the impact of GLP-1R agonists in postsinus surgery management.mp4
- Day 2 Skull Base – Breakout 1 Autologous vs synthetic inlay grafts have comparable skull base reconstructive outcomes.mp4
- Day 2 Skull Base – Breakout 1 Debate- Approaches to the Lateral Frontal Sinus.mp4
- Day 2 Skull Base – Breakout 1 Extended approaches to the maxillary sinus and empty nose syndrome.mp4
- Day 2 Skull Base – Breakout 1 Factors influencing CSF leak timing after ESBS.mp4
- Day 2 Skull Base – Breakout 1 Long-term implications of short-term outcomes after ESS in CRS patients.mp4
- Day 2 Skull Base – Breakout 1 Maxillary antrostomy alone versus complete sinus surgery for odontogenic sinusitis.mp4
- Day 2 Skull Base – Breakout 1 Mutational burden assessment in sinonasal squamous cell carcinoma survival.mp4
- Day 2 Skull Base – Breakout 1 Orbital decompression in the biologic era- Is there still a need for surgery.mp4
- Day 2 Skull Base – Breakout 1 Panel Evolving Principles for Systemic Therapies in Management of Sinonasal Malignancy 1.mp4
- Day 2 Skull Base – Breakout 1 Panel Evolving Principles for Systemic Therapies in Management of Sinonasal Malignancy 2.mp4
- Day 2 Skull Base – Breakout 1 Panel Evolving Principles for Systemic Therapies in Management of Sinonasal Malignancy 3.mp4
- Day 2 Skull Base – Breakout 1 Panel Evolving Principles for Systemic Therapies in Management of Sinonasal Malignancy 4.mp4
- Day 2 Skull Base – Breakout 1 Panel- “Carve it Out or Melt it Away – Induction Chemotherapy versus Upfront Surgery for Sinonasal Malignancies”.mp4
- Day 2 Skull Base – Breakout 1 Q&A 1.mp4
- Day 2 Skull Base – Breakout 1 Q&A 2.mp4
- Day 2 Skull Base – Breakout 1 Q&A 3.mp4
- Day 2 Skull Base – Breakout 1 Q&A 4.mp4
- Day 2 Skull Base – Breakout 1 Retrobulbar amphotericin B injections versus orbital exenteration in AIFRS outcomes.mp4
- Day 2 Skull Base – Breakout 1 Social vulnerability and quality of life before and after endoscopic skull base surgery.mp4
- Day 2 Skull Base – Breakout 1 The effect of anticoagulant therapy on endoscopic sinus surgery postoperative outcomes.mp4
- Day 2 Skull Base – Breakout 1 Understanding endoscopy and imaging frequency for detection of sinonasal SCC recurrence.mp4
- Day 2 Skull Base – Breakout 1 Unilateral versus bilateral resection of olfactory neuroblastoma.mp4
- Day 2 Skull Base – Breakout 1 Upfront Draf III – Cost-effective in the long run.mp4
- Day 2 Skull Base – Breakout 1 Validation of the sinonasal outcome test-22 in sinonasal malignancy.mp4
